Clinical Trial Update: Iron Chelation in the Prevention of Secondary Degeneration After Stroke [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating iron chelation to prevent secondary degeneration after stroke has been terminated. The study is no longer active.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Iron chelation therapy (unspecified)

Snippet

Sponsor: University Hospital, Bordeaux | Conditions: Stroke | Phase 2 | Status: TERMINATED